Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 2
2005 1
2006 1
2007 2
2008 1
2009 1
2010 1
2011 1
2012 4
2013 2
2014 3
2016 2
2017 1
2018 3
2019 4
2020 2
2021 4
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
Elizalde-Torrent A, Borgognone A, Casadellà M, Romero-Martin L, Escribà T, Parera M, Rosales-Salgado Y, Díaz-Pedroza J, Català-Moll F, Noguera-Julian M, Brander C, Paredes R, Olvera A. Elizalde-Torrent A, et al. Among authors: parera m. Vaccines (Basel). 2023 Oct 30;11(11):1663. doi: 10.3390/vaccines11111663. Vaccines (Basel). 2023. PMID: 38005995 Free PMC article.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Podzamczer D, et al. Among authors: parera m. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. J Antimicrob Chemother. 2023. PMID: 37725999 Clinical Trial.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Borgognone A, Elizalde-Torrent A, Casadellà M, Romero L, Escribà T, Parera M, Català-Moll F, Noguera-Julian M, Brander C, Olvera A, Paredes R. Borgognone A, et al. Among authors: parera m. NPJ Biofilms Microbiomes. 2022 Dec 30;8(1):104. doi: 10.1038/s41522-022-00368-y. NPJ Biofilms Microbiomes. 2022. PMID: 36585401 Free PMC article.
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C, Parera M, Català-Moll F, Casadellà M, Elizalde-Torrent A, Aguiló M, Espadaler-Mazo J, Santos JR, Paredes R, Noguera-Julian M. Blázquez-Bondia C, et al. Among authors: parera m. Front Immunol. 2022 Dec 8;13:1066036. doi: 10.3389/fimmu.2022.1066036. eCollection 2022. Front Immunol. 2022. PMID: 36569851 Free PMC article. Clinical Trial.
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.
Bordoy AE, Saludes V, Panisello Yagüe D, Clarà G, Soler L, Paris de León A, Casañ C, Blanco-Suárez A, Guerrero-Murillo M, Rodríguez-Ponga B, Noguera-Julian M, Català-Moll F, Pey I, Armengol MP, Casadellà M, Parera M, Pluvinet R, Sumoy L, Clotet B, Giménez M, Martró E, Cardona PJ, Blanco I. Bordoy AE, et al. Among authors: parera m. Sci Rep. 2022 Dec 17;12(1):21818. doi: 10.1038/s41598-022-25719-9. Sci Rep. 2022. PMID: 36528712 Free PMC article.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Bailón L, Llano A, Cedeño S, Escribà T, Rosás-Umbert M, Parera M, Casadellà M, Lopez M, Pérez F, Oriol-Tordera B, Ruiz-Riol M, Coll J, Perez F, Rivero À, Leselbaum AR, McGowan I, Sengupta D, Wee EG, Hanke T, Paredes R, Alarcón-Soto Y, Clotet B, Noguera-Julian M, Brander C, Molto J, Mothe B; AELIX002 Study Group. Bailón L, et al. Among authors: parera m. Nat Med. 2022 Dec;28(12):2611-2621. doi: 10.1038/s41591-022-02060-2. Epub 2022 Oct 27. Nat Med. 2022. PMID: 36302893 Clinical Trial.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain.
Fernández-Bastit L, Marfil S, Pradenas E, Valle R, Roca N, Rodon J, Pailler-García L, Trinité B, Parera M, Noguera-Julian M, Martorell J, Izquierdo-Useros N, Carrillo J, Clotet B, Blanco J, Vergara-Alert J, Segalés J. Fernández-Bastit L, et al. Among authors: parera m. Transbound Emerg Dis. 2022 Nov;69(6):3518-3529. doi: 10.1111/tbed.14714. Epub 2022 Oct 7. Transbound Emerg Dis. 2022. PMID: 36167932 Free PMC article.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Borgognone A, Noguera-Julian M, Oriol B, Noël-Romas L, Ruiz-Riol M, Guillén Y, Parera M, Casadellà M, Duran C, Puertas MC, Català-Moll F, De Leon M, Knodel S, Birse K, Manzardo C, Miró JM, Clotet B, Martinez-Picado J, Moltó J, Mothe B, Burgener A, Brander C, Paredes R; BCN02 Study Group. Borgognone A, et al. Among authors: parera m. Microbiome. 2022 Apr 11;10(1):59. doi: 10.1186/s40168-022-01247-6. Microbiome. 2022. PMID: 35410461 Free PMC article. Clinical Trial.
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
Fernández-Bastit L, Rodon J, Pradenas E, Marfil S, Trinité B, Parera M, Roca N, Pou A, Cantero G, Lorca-Oró C, Carrillo J, Izquierdo-Useros N, Clotet B, Noguera-Julián M, Blanco J, Vergara-Alert J, Segalés J. Fernández-Bastit L, et al. Among authors: parera m. Viruses. 2021 Dec 16;13(12):2526. doi: 10.3390/v13122526. Viruses. 2021. PMID: 34960795 Free PMC article.
44 results